HGV/GBV-C infection in liver transplant recipients: Antibodies to the viral E2 envelope glycoprotein protect from de novo infection

Journal of Hepatology

Volumn 29, Issue 4, 1998, Pages 533-540

  Silini, Enrico ^b   Belli, Luca ^a   Alberti, Alberto B ^a   Asti, Margherita ^b   Cerino, Antonella ^b   Bissolati, Morena ^b   Rondinara, Gianfranco ^c   De Carlis, Luciano ^c   Forti, Domenico ^c   Mondelli, Mario U ^b   Ideo, Gaetano ^a,c  

^a Center for Liver Diseases   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Anti E2 antibodies; GBV C; HGV; Liver transplant; Recurrent hepatitis

Indexed keywords

GLYCOPROTEIN;

ADULT; ARTICLE; DISEASE COURSE; FEMALE; HEPATITIS G VIRUS; HEPATITIS NON A NON B; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; VIREMIA;

EID: 0032192273     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80147-5     Document Type: Article

References (39)

1. 1. Fagiuoli S, Leandro G, Bellati G, Gasbarrini A, Rapaccini GL, Pompili M, et al. and the Monotematica AISF Study Group. Liver transplantation in Italy: preliminary 10-year report. Ital J Gastroenterol 1996; 28: 343-50.
2. 2. Alter HJ, Bradley DW. Non-A, non-B hepatitis unrelated to the hepatitis C virus (non-ABC). Semin Liver Dis 1995; 15: 110-20.
3. 3. Bradley DW, Maynard JE, Popper H, Cook EH, Ebert JW, McCaustland KA, et al. Posttransfusion non-A, non-B hepatitis: physicochemical properties of two distinct agents. J Infect Dis 1983; 148: 254-65.
4. 4. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, et al. for the Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992; 327: 1899-905.
5. 5. Rochling FA, Jones WF, Chau K, DuCharme L, Minims LT, Moore B, et al. Acute sporadic non-A, non-B, non-C, non-D, non-E hepatitis. Hepatology 1997; 25: 478-83.
6. 6. Diodati G, Tagger A, Bonetti P, Ribero M, Drago C, Caaletto D, et al. Antibody to hepatitis C virus in cryptogenic chronic liver disease. J Med Virol 1991; 35: 151-4.
7. 7. Kodali V, Gordon S, Silverman A, McCray D Cryptogenic liver disease in the United States: further evidence for non-A, non-B, and non-C hepatitis. Am J Gastroenterol 1994; 89: 1836-9.
8. 8. Feray C, Gigou M, Samuel D, Reyes G, Bernuau J, Reynes M, et al. Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. Gastroenterology 1992; 103: 549-55.
9. 9. Liang TJ, Jeffers L, Reddy RK, Silva MO, Cheinquer H, Findor A, et al. Fulminant or subfulminant non-A, non-B viral hepatitis: the role of hepatitis C and E viruses. Gastroenterology 1992; 103: 556-62.
10. 10. Wright TL. Etiology of fulminant hepatic failure: is another virus involved? Gastroenterology 1993; 104: 640-3.
11. 11. Slapak GI, Saxena R, Portmann B, Gane E, Devlin J, Calne SR, et al. Graft and systemic disease in long-term survivors of liver transplantation. Hepatology 1997; 25: 195-205.
12. 12. Pessoa MG, Terrault NA, Ferrell LD, Kim JP, Kolberg J, Detmer J, et al. Hepatitis G virus in patients with cryptogenic liver disease undergoing liver transplantation. Hepatology 1997; 25: 1266-70.
13. 13. Mohamed R, Hubscher SG, Mirza DF, Gunson BK, Mutimer DJ. Posttransplantation chronic hepatitis in fulminant hepatic failure. Hepatology 1997; 25: 1003-7.
14. 14. Linnen J, Wages J, Zhang-Keck Z-Y, Fry KE, Krawczynski KZ, Alter H, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996; 271: 505-8.
15. 15. Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nature Med 1995; 1: 564-9.
16. 16. Tacke M, Kiyosawa K, Stark K, Sclueter V, Ofenloch-Haehnle B, Hess G, et al. Detection of antibodies to a putative hepatitis G virus envelope protein. Lancet 1997; 349: 318-20.
17. 17. Feucht HH, Zollner B, Polywka S, Knodler B, Schroter M, Nolte H, et al. Distribution of hepatitis G viremia and antibody response to recombinant proteins with special regard to risk factors in 709 patients. Hepatology 1997; 26: 491-4.
18. 18. Masuko K, Mitsui T, Iwano K, Yamazaki C, Okuda K, Meguro T, et al. Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med 1996; 334: 1485-90.
19. 19. Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 1995; 346: 1131-2.
20. 20. Heringlake S, Osterkamp S, Trautwein C, Tillman HL, Böker K, Muerhoff S, et al. Association between fulminant hepatic failure and a strain of GBV virus C. Lancet 1996; 348: 1626-9.
21. 21. Alter HJ, Nakatsuji Y, Melpolder J, Wages J, Welsey R, Shih JW-H, et al. The incidence of transfusion associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997; 336: 747-54.
22. 22. Alter MJ, Gallagher M, Moris TT, Moyer LA, Meeks EL, Krawczynski K, et al. for the Sentinel Counties Viral Hepatitis Study Team. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. N Engl J Med 1997; 336: 741-6.
23. 23. Kanda T, Yokosuka O, Ehata T, Maru Y, Imazeki F, Saisho H, et al. Detection of GBV-C RNA in patients with non-A-E fulminant hepatitis by reverse-transcription polymerase chain reaction. Hepatology 1997; 25: 1261-5.
24. 24. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-20.
25. 25. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-penol-chloroform ex-traction. Anal Biochem 1987; 162: 156-9.
26. 26. Silini EM, Bono F, Cividini A, Cerino A, Bruno S, Rossi S, et al. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. Hepatology 1995; 21: 285-90.
27. 27. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992; 73: 673-9.
28. 28. Okamoto H, Tokita H, Sakamoto M, Horikita M, Kojima M, Iizuka H, et al. Characterization of the genomic sequence of type V (or 3 a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol 1993; 74: 2385-90.
29. 29. Belli LS, Silini E, Alberti A, Bellati G, Vai C, Minola E, et al. HCV genotypes, hepatitis, and HCV recurrence after liver transplantation. Liver Transpl Surg 1995; 2: 1-7.
30. 30. Muerhoff AS, Smith DB, Leary TP, Erker JC, Desai SM, Mushahwar IK. Identification of GB virus C variants by phylogenetic analysis of 5′-untranslated and coding region sequences. J Virol 1997; 71: 6501-8.
31. 31. Berenguer M, Terrault NA, Piatak M, Yun A, Kim JP, Lau JYN, et al. Hepatitis G virus infection in patients with hepatitis C virus infection undergoing liver transplantation. Gastroenterology 1996; 111: 1569-75.
32. 32. Berg T, Naumann U, Fukumoto T, Bechstein WO, Neuhaus P, Lobeck H, et al. GB virus C infection in patients with chronic hepatitis B and C before and after liver transplantation. Transplantation 1996; 62: 711-4.
33. 33. Fried MW, Khudyakov YE, Smallwood GA, Cong M, Nichols B, Diaz E, et al. Hepatitis G virus co-infection in liver transplantation recipients with chronic hepatitis C and non-viral chronic liver disease. Hepatology 1997; 25: 1271-5.
34. 34. Viazov S, Riffelmann M, Sarr S, Ballauff A, Meisel H, Roggendorf M. Transmission of GBV-C/HGV from drug-addicted mothers to their babies. J Hepatol 1997; 27: 85-90.
35. 35. Kao J-H, Chen P-J, Lai M-Y, Chen W, Liu D-P, Wang J-T, et al. GB virus-C/hepatitis G virus infection in an area endemic for viral hepatitis, chronic liver disease and liver cancer. Gastroenterology 1997; 112: 1265-70.
36. 36. Cotler SJ, Gretch DR, Bronner MP, Tateyama H, Emond MJ, dela Rosa C, et al. Hepatitis G virus co-infection does not alter the course of recurrent hepatiits C virus infection in liver transplantation recipients. Hepatology 1997; 26: 432-6.
37. 37. Dickson RC, Quian KP, Lau JY. High prevalence of GB virus-C/hepatitis G virus infection in liver transplant recipients. Transplantation 1997; 63: 1695-7.
38. 38. Haagsma ER, Cuypers HTM, Gouw ASH, Sjerps MC, Huizenga JR, Slooff MJH, et al. High prevalence of hepatitis G virus after liver transplantation without apparent influence on long-term graft function. J Hepatol 1997; 26: 921-5.
39. 39. Colombatto P, Randone A, Civitico G, Monti Gorin J, Dolci L, Medaina N, et al. Hepatitis G virus RNA in the serum of patients with elevated gamma glutamyl transpeptidase and alkaline phosphatase: a specific liver disease. J Viral Hepatitis 1996; 3: 301-6.